On Tuesday, Procept BioRobotics Corp (NASDAQ: PRCT) opened lower -5.38% from the last session, before settling in for the closing price of $69.75. Price fluctuations for PRCT have ranged from $45.20 to $103.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 142.74%. Company’s average yearly earnings per share was noted 22.27% at the time writing. With a float of $51.53 million, this company’s outstanding shares have now reached $52.15 million.
Let’s determine the extent of company efficiency that accounts for 626 employees. In terms of profitability, gross margin is 56.09%, operating margin of -53.27%, and the pretax margin is -50.07%.
Procept BioRobotics Corp (PRCT) Insider Activity
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Procept BioRobotics Corp is 5.27%, while institutional ownership is 87.52%. The most recent insider transaction that took place on Dec 04 ’24, was worth 2,568,844. In this transaction President, CEO of this company sold 26,423 shares at a rate of $97.22, taking the stock ownership to the 152,762 shares. Before that another transaction happened on Dec 04 ’24, when Company’s EVP, CLO, CORP. SEC. sold 28,092 for $97.13, making the entire transaction worth $2,728,574. This insider now owns 52,472 shares in total.
Procept BioRobotics Corp (PRCT) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.33 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.27% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.35% during the next five years compared to -23.27% drop over the previous five years of trading.
Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators
Check out the current performance indicators for Procept BioRobotics Corp (PRCT). In the past quarter, the stock posted a quick ratio of 5.07. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 17.96.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.30 in one year’s time.
Technical Analysis of Procept BioRobotics Corp (PRCT)
Looking closely at Procept BioRobotics Corp (NASDAQ: PRCT), its last 5-days average volume was 0.65 million, which is a drop from its year-to-date volume of 0.85 million. As of the previous 9 days, the stock’s Stochastic %D was 9.16%. Additionally, its Average True Range was 3.64.
During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 0.47%, which indicates a significant decrease from 1.70% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 44.21% in the past 14 days, which was lower than the 64.27% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $81.88, while its 200-day Moving Average is $74.56. However, in the short run, Procept BioRobotics Corp’s stock first resistance to watch stands at $68.13. Second resistance stands at $70.25. The third major resistance level sits at $71.41. If the price goes on to break the first support level at $64.85, it is likely to go to the next support level at $63.69. Should the price break the second support level, the third support level stands at $61.57.
Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats
There are currently 52,183K shares outstanding in the company with a market cap of 3.59 billion. Presently, the company’s annual sales total 136,190 K according to its annual income of -105,900 K. Last quarter, the company’s sales amounted to 58,370 K and its income totaled -20,970 K.
